Ascendis Pharma ADR (ASND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -373,441 | -258,903 | -142,265 | -521,070 | -429,449 |
| Depreciation Amortization | 14,558 | 9,547 | 4,861 | 20,467 | 15,166 |
| Accounts receivable | 6,808 | -24,496 | -12,253 | -35,470 | -26,394 |
| Accounts payable and accrued liabilities | -19,824 | -11,384 | -20,655 | 3,843 | 14,807 |
| Other Working Capital | 7,907 | -2,459 | -56,282 | -107,998 | -77,801 |
| Other Operating Activity | 123,156 | 112,279 | 116,307 | 134,403 | 41,220 |
| Operating Cash Flow | $-240,836 | $-175,416 | $-110,288 | $-505,825 | $-462,451 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 8,087 | 7,920 | 7,984 | 312,639 | 307,236 |
| PPE Investments | -103 | 441 | -216 | -2,588 | -2,676 |
| Investing Cash Flow | $7,983 | $8,360 | $7,768 | $310,051 | $304,559 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 147,520 | N/A | -3,025 | 147,470 | 152,139 |
| Debt Repayment | -9,256 | -6,037 | N/A | N/A | N/A |
| Common Stock Issued | 349,785 | 23,233 | 23,027 | 11,133 | 8,999 |
| Other Financing Activity | 0 | 0 | 0 | -13,258 | -8,384 |
| Financing Cash Flow | $488,049 | $17,196 | $20,002 | $145,344 | $152,754 |
| Exchange Rate Effect | 1,397 | 6,129 | 4,429 | -6,503 | 1,330 |
| Beginning Cash Position | 431,224 | 422,321 | 425,773 | 481,371 | 484,084 |
| End Cash Position | 687,816 | 278,590 | 347,684 | 424,439 | 480,276 |
| Net Cash Flow | $256,593 | $-143,732 | $-78,089 | $-56,932 | $-3,808 |
| Free Cash Flow | |||||
| Operating Cash Flow | -240,836 | -175,416 | -110,288 | -505,825 | -462,451 |
| Capital Expenditure | -1,148 | -583 | -216 | -2,643 | -2,726 |
| Free Cash Flow | -241,984 | -175,999 | -110,504 | -508,468 | -465,178 |